Skip to main content
OpenTrials
Completed

NCT Number: NCT03221283

The Application of Music Therapy in Female Amphetamine Use Disorder

The group music therapy will be used to treat female amphetamine-type stimulant (ATS) addiction

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Amphetamine Addiction Amphetamine-Related Disorders Behavior Behavioral Symptoms Chemically-Induced Disorders Depression Mental Disorders Substance-Related Disorders

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Shanghai Women's Compulsory Isolation Detoxification Center

Shanghai, China

About this study

Amphetamine addicts are often accompanied by severe emotional problems and are difficult to control and regulate negative emotions by themselves.And the emotional problems are high risk factors of addicts relapse. Music therapy as the intervention is in order to improve amphetamine addicts' emotional status and the ability of emotion regulation. Self-rating Depression Scale(SDS), Self-rating Anxiety scale(SAS) will be used to investigate the emotion of participants. These methods will also be used to evaluate the efficacy of the intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • In accordance with the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) for methamphetamine (MA) use disorder
  • Junior high school degree or above
  • Normal vision and hearing
  • Have emotional problem

Exclusion criteria

  • Other substance abuse or dependence in recent a years (except nicotine)
  • Mental impairment, Intelligence Quotient (IQ) < 70
  • Mental disorders
  • Physical disease

Treatment and study plan

Music therapy group

Behavioral

The experimental group received 13 group music sessions over a three-month period. Different method of music therapy will be used to improve the emotion experience, emotion regulation, emotional control and emotional expression.

Primary outcomes

  1. Change from Baseline Depression status assessed by Self-rating Depression Scale (SDS) at 4 months.

    Time frame: Baseline, 2 months,4 months, and 7months

    evaluate all participants' depression status by Self-rating Depression Scale (SDS)

Secondary outcomes

  1. Anxiety status assessed by Self-rating Anxiety Scale (SAS)

    Time frame: Baseline, 2 months,4 months, and 7months

    evaluate all participants' anxiety status by Self-rating Anxiety Scale (SAS)

  2. Change from Baseline Craving for ATS assessed by Visual Analog Scales (VAS)

    Time frame: Baseline, 2 months,4 months, and 7months

    evaluate all participants' craving for ATS by Visual Analog Scales (VAS)

  3. Empathy ability assessed by Interpersonal Reactivity Index-C(IRI-C)

    Time frame: Baseline, 2 months,4 months, and 7months

    evaluate all participants' Empathy ability by Interpersonal Reactivity Index-C(IRI-C)

  4. Motivation for treatment assessed by Stages of Change Readiness and Treatment Eagerness Scale(SOCRATES)

    Time frame: Baseline, 2 months,4 months, and 7months

    evaluate all participants' motivation for treatment assessed by Stages of Change Readiness and Treatment Eagerness Scale(SOCRATES)

  5. Change from Baseline emotional status assessed by emotional STROOP paradigm

    Time frame: Baseline, 2 months,4 months, and 7months

    evaluate all participants' emotional status by emotional STROOP paradigm

  6. Sleep status assessed by Pittsburgh Sleep Quality Index(PSQI)

    Time frame: Baseline, 2 months,4 months, and 7months

    evaluate all participants' sleep status by Pittsburgh Sleep Quality Index(PSQI)

Sponsors and collaborators

Lead sponsor

Shanghai Mental Health Center

Other

Registry information

Official study title

The Intervention of Group Therapy: Music in Mood Problems of Female Amphetamine Use Disorder

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Jul 18, 2017
Registry last updated
Nov 20, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.